Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice

Behavioural Pharmacology

Volumn 22, Issue 2, 2011, Pages 182-190

  Rehni, Ashish K ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

morphine dependence; mouse; src family kinase; withdrawal syndrome

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MOVEMENT; CIRCLING BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FEMALE; JUMPING; MALE; MOUSE; NONHUMAN; REARING; WITHDRAWAL SYNDROME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; INDOLES; MALE; MICE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; SEVERITY OF ILLNESS INDEX; SRC-FAMILY KINASES; SUBSTANCE WITHDRAWAL SYNDROME; SULFONAMIDES;

EID: 79952987481     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328343d7a0     Document Type: Article

References (45)

1. Akil H, Lewis JW, editors (1987). In: neurotransmitters and pain control, vol. 9: pain and headache. Basil: Karger. pp. 129-159.
2. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, Vogel Z (1996). Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma. J Biol Chem 271:21309-21315. (Pubitemid 26292991)
3. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, Vogel Z (1997). Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272: 5040-5047. (Pubitemid 27090057)
4. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA (2000). SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 20:9018-9027. (Pubitemid 32245931)
5. Chakrabarti S, Oppermann M, Gintzler AR (2001). Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci USA 98:4209-4214. (Pubitemid 32249923)
6. D'Amour FE, Smith DL (1941). A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74.
7. Falls WA, Kelsey JE (1989). Procedures that produce context-specific tolerance to morphine in rats also produce context-specific withdrawal. Behav Neurosci 103:842-849. (Pubitemid 19218417)
8. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR (2005). A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem 280:38478-38488. (Pubitemid 43853746)
9. Garzón J, Rodŕguez-Muñoz M, Sánchez- Blázquez P (2008). Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev 1:222-238.
10. George SR, Fan T, Xie Z,Tse R,Tam V,Varghese G, et al. (2000). Oligomerization of mu- and delta-opioid receptors generation of novel functional properties. J Biol Chem 275:26128-26135.
11. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, et al. (2003). Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111. (Pubitemid 36531950)
12. Glick SD, Morihisa JM (1976). Changes in sensitivity of morphine-induced circling behaviour after chronic treatment and persistence after withdrawal in rats. Nature 260:159-161.
13. Hardman JG, Limbird LE, Gilman AG, editors (2001). In: Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw Hill. pp. 631-634.
14. Hong MH, Xu C, Wang YJ, Ji JL, Tao YM, Xu XJ, et al. (2009). Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J Neurochem 108:102-114.
15. Inoue M, Mishina M, Ueda H (2003). Locus specific rescue of GluR-1NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 23:6529-6536. (Pubitemid 36909879)
16. Koob GF, Bloom FE (1988). Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
17. Krantz MJ, Mehler PS (2004). Treating opioid dependence growing implications for primary care. Arch Intern Med 164:277-288. (Pubitemid 38180528)
18. Law PY, Hom DS, Loh HH (1982). Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment: a multiple-step process. Mol Pharmacol 22:1-4. (Pubitemid 12097253)
19. Law PY, Wong YH, Loh HH (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430. (Pubitemid 30340688)
20. Lee S, Rosenberg CR, Musacchio M (1987). Cross-dependence to opioid and a2-adrenergic receptor agonists in NG1O8-15 cells. FASEB J 2:52-55.
21. Liu JG, Anand KJ (2001). Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1e19.
22. Liu Z, Zheng JF, Yang LQ, Yi L, Hu B (2007). Effects of sinomenine on NO/nNOS system in cerebellum and spinal cord of morphine-dependent and withdrawal mice. Sheng Li Xue Bao 59:285-292.
23. Liu Q, Wang X, Liu Y, Lu R, Yuan Q, Yang B, et al. (2010). RACK1 inhibits morphine re-exposure via inhibition of Src. Neurol Res 2011. [Epub ahead of print]
24. Loguinov AV, Anderson LM, Crosby GJ, Yukhananov RY (2001). Gene expression following acute morphine administration. Physiol Genomics 6: 169-181. (Pubitemid 33676486)
25. Marshall J, Graham-Smith DG (1971). Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice. J Pharmacol Exp Ther 173:634-641.
26. Mostany R, Daz A,Valdizan EM, Rodrguez-Munoz M, Garzon J, Hurle MA (2008). Supersensitivity to m-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Ga protein subunits. Neuropharmacol 54:989-997.
27. Narita M, Kato H, Kasukawa A, Narita M, Suzuki M, Takeuchi T, et al. (2006). Role of Src family kinase in the rewarding effect and hyperlocomotion induced by morphine. Neuroreport 17:115-119. (Pubitemid 43100311)
28. Nestler EJ (2004). Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210-218. (Pubitemid 38519912)
29. Patkina NA, Zvartau EE (1978). Rat behavior in an 'open field' when chronically administered morphine. Farmakol Toksikol 41:537-541. (Pubitemid 9010212)
30. Pineyro G, Archer-Lahlou E (2007). Ligand-specific receptor states: implications for opiate receptor signalling and regulation. Cell Signal 19:8-19. (Pubitemid 44880245)
31. Reddy DS, Kulkarni SK (1998). Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res 799:215-229. (Pubitemid 28351250)
32. Rehni AK, Bhateja P, Singh TG, Singh N (2008a). Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behav Pharmacol 19:265-269. (Pubitemid 351670407)
33. Rehni AK, Singh I, Singh N, Bansal N, Bansal S, Kumar M (2008b). Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Eur J Pharmacol 598:51-56.
34. Sánchez-Blázquez P, Rodŕguez-Muñoz M, De la Torre-Madrid E, Garzón J (2009). Brain-specific G alphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway. Cell Signal 21: 1444-1454.
35. Sarnago S, Elorza A, Mayor F (1999). Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem 274:34411-34416. (Pubitemid 129511786)
36. Schlessinger J (2000). New roles for Src kinases in control of cell survival and angiogenesis. Cell 100:293-296. (Pubitemid 30353084)
37. Sharma KS, Klee WA, Nirenberg M (1977). Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci USA 74:3365-3369.
38. Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, et al. (2002). Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone precipitated morphine withdrawal. J Neurosci 22:3663-3672. (Pubitemid 37465771)
39. Thomas SM, Brugge JS (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609. (Pubitemid 28034534)
40. Van Ree JM, Gerrits MAFM, Vanderschuren LJMJ (1999). Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51:341-396. (Pubitemid 29269983)
41. Walwyn W, Evans CJ, Hales TG (2007). Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons. J Neurosci 27:5092-5104. (Pubitemid 46741772)
42. Way EL, Loh HH, Shen FH (1969). Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167: 1-8.
43. Williams JT, Christie MJ, Manzoni O (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343. (Pubitemid 32096178)
44. World Health Organisation (2003). Management of Substance Dependence, http://www.who.int/substance-abuse.
45. Zhang L, Zhao H, Qiu Y, Loh HH, Law PY (2009). Src phosphorylation of m-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signals. J Biol Chem 284:1990-2000.